[IMRX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[IMRX] Immuneering Corporation
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 8,590.32%
YoY- 8,352.11%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue -94,419 0 94,419 0 0 38 94 -
PBT -15,084 -12,595 -12,189 -13,604 -13,246 -12,844 -11,527 19.57%
Tax -755 -13,912,372 -1,139 -1,075,403 -740 -344 -52 492.26%
NP -15,083 -12,595 -12,189 1,061,799 -12,506 -12,501 -11,527 19.57%
Tax Rate - - - - - - - -
Total Cost -79,336 12,595 106,608 -1,061,799 12,506 12,539 11,622 -
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 15.98 0.00 -12.91 0.00 -2,742,434.65 -32,570.38 -12,208.67 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.52 -0.43 -0.43 40.16 -0.47 -0.47 -0.44 11.74%
EPS Diluted -0.52 -0.43 -0.43 40.16 -0.47 -0.47 -0.44 11.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.